Yıl: 2019 Cilt: 6 Sayı: 1 Sayfa Aralığı: 40 - 47 Metin Dili: İngilizce DOI: 10.14744/nci.2018.69335 İndeks Tarihi: 20-05-2020

Relation of multicenter automatic defibrillator implantation trial implantable cardioverter-defibrillator score with long-term cardiovascular events in patients with implantable cardioverter-defibrillator

Öz:
OBJECTIVE: To test the hypothesis that multicenter automatic defibrillator implantation trial (MADIT) - implantable cardioverter-defibrillator (ICD) scores predict replacement requirement and appropriate shock in a mixed population includingboth primary and secondary prevention and long-term adverse cardiovascular events.METHODS: The study has a retrospective design. Patients who were implanted with ICD in the cardiology clinic of AtatürkUniversity Faculty of Medicine between 2000 and 2013 were included in the study. For this purpose, 1394 patients who wereimplanted with a device in our clinic were reviewed. Then, those who were implanted with permanent pacemaker (n=1005),cardiac resynchronization treatment (CRT) (n=45) and CRT-ICD (n=198) were excluded.RESULTS: A total of 146 patients (98 males, 67.1%) with a mean age of 61.1 (±14.8) years were recruited. The medianfollow-up time was 21.5 months (mean 30.6±25.9 months; minimum 4 months, and maximum 120 months). The medianMADIT-ICD scores in the patients were 2. MADIT-ICD scores were categorized as low in 15.1%, intermediate in 57.5%, andhigh score in 27.4% of patients. Accordingly, MADIT-ICD scores (1.29 [1.00–1.68], p=0.050), hemoglobin (0.86 [0.75–0.99],p=0.047), and left ventricular ejection fraction (EF) (0.97 [0.94–0.99], p=0.023) were determined as independent predictorsof major adverse cardiovascular events in the long-term follow-up of ICD-implanted population.CONCLUSION: In this study, we showed that there was an independent association of long-term adverse cardiovascularevents with MADIT-ICD score, hemoglobin, and EF in patients implanted with ICD.
Anahtar Kelime:

Konular: Genel ve Dahili Tıp
Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • 1. Connolly SJ, Hallstrom AP, Cappato R, Schron EB, Kuck KH, Zipes DP, et al. Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies. Antiarrhythmics vs implantable defibrillator study. Cardiac arrest study hamburg. Canadian implantable defibrillator study. Eur Heart J 2000;21:2071–8. [CrossRef ]
  • 2. Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002;346:877– 83. [CrossRef ]
  • 3. Barsheshet A, Moss AJ, Huang DT, McNitt S, Zareba W, Goldenberg I, et al. Applicability of a risk score for prediction of the long-term (8- year) benefit of the implantable cardioverter-defibrillator. J Am Coll Cardiol 2012;59:2075–9. [CrossRef ]
  • 4. Goldenberg I, Vyas AK, Hall WJ, Moss AJ, Wang H, He H, et al. Risk stratification for primary implantation of a cardioverter-defibrillator in patients with ischemic left ventricular dysfunction. J Am Coll Cardiol 2008;51:288–96. [CrossRef ]
  • 5. Braunwald E, Zipes DP, Libby P, Bonow RO. Heart Disease: A Textbook of Cardiovascular Medicine. 8th ed. Philedelphia, PA: Saunders Elsevier; 2008. p. 933–74.
  • 6. Spooner PM, Albert C, Benjamin EJ, Boineau R, Elston RC, George AL Jr., et al. Sudden cardiac death, genes, and arrhythmogenesis: Consideration of new population and mechanistic approaches from a national heart, lung, and blood institute workshop, part I. Circulation 2001;103:2361–4. [CrossRef ]
  • 7. Cummins RO, Ornato JP, Thies WH, Pepe PE. Improving survival from sudden cardiac arrest: The “chain of survival” concept. A statement for health professionals from the advanced cardiac life support subcommittee and the emergency cardiac care committee, American heart association. Circulation 1991;83:1832–47. [CrossRef ]
  • 8. Bayés de Luna A, Coumel P, Leclercq JF. Ambulatory sudden cardiac death: Mechanisms of production of fatal arrhythmia on the basis of data from 157 cases. Am Heart J 1989;117:151–9. [CrossRef ]
  • 9. Buxton AE, Fisher JD, Josephson ME, Lee KL, Pryor DB, Prystowsky EN, et al. Prevention of sudden death in patients with coronary artery disease: The multicenter unsustained tachycardia trial (MUSTT). Prog Cardiovasc Dis 1993;36:215–26. [CrossRef ]
  • 10. Moss AJ, Hall WJ, Cannom DS, Daubert JP, Higgins SL, Klein H, et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter automatic defibrillator implantation trial investigators. N Engl J Med 1996;335:1933–40. [CrossRef ]
  • 11. Bigger JT Jr., Fleiss JL, Kleiger R, Miller JP, Rolnitzky LM. The relationships among ventricular arrhythmias, left ventricular dysfunction, and mortality in the 2 years after myocardial infarction. Circulation 1984;69:250–8. [CrossRef ]
  • 12. Pedersen SS, Van Den Broek KC, Van Den Berg M, Theuns DA. Shock as a determinant of poor patient-centered outcomes in implantable cardioverter defibrillator patients: Is there more to it than meets the eye? Pacing Clin Electrophysiol 2010;33:1430–6. [CrossRef ]
  • 13. Bigger JT Jr. Prophylactic use of implanted cardiac defibrillators in patients at high risk for ventricular arrhythmias after coronary-artery bypass graft surgery. Coronary artery bypass graft (CABG) patch trial investigators. N Engl J Med 1997;337:1569–75. [CrossRef ]
  • 14. Theuns DA, Res JC, Jordaens LJ. Home monitoring in ICD therapy: Future perspectives. Europace 2003;5:139–42. [CrossRef ]
  • 15. Bokhari F, Newman D, Greene M, Korley V, Mangat I, Dorian P, et al. Long-term comparison of the implantable cardioverter defibrillator versus amiodarone: Eleven-year follow-up of a subset of patients in the Canadian implantable defibrillator study (CIDS). Circulation 2004;110:112–6. [CrossRef ]
  • 16. Vandenberk B, Hinderks M, Voros G, Garweg C, Vanhaecke J, Willems R, et al. The evolution and benefit of device therapy in patients listed for heart transplant. Europace 2018;20:786–93. [CrossRef ]
  • 17. Cygankiewicz I, Gillespie J, Zareba W, Brown MW, Goldenberg I, Klein H, et al. Predictors of long-term mortality in multicenter automatic defibrillator implantation trial II (MADIT II) patients with implantable cardioverter-defibrillators. Heart Rhythm 2009;6:468–73.
  • 18. Naksuk N, Akkaya M, Adabag S. Application of the multicenter automatic defibrillator implantation trial II risk score in a nontrial setting. Am J Cardiol 2013;112:530–2. [CrossRef ]
APA uslu A, Doğan C, duman h, TANBOĞA İ, askin l, SEVİMLİ S (2019). Relation of multicenter automatic defibrillator implantation trial implantable cardioverter-defibrillator score with long-term cardiovascular events in patients with implantable cardioverter-defibrillator. , 40 - 47. 10.14744/nci.2018.69335
Chicago uslu Abdulkadir,Doğan Cem,duman hakan,TANBOĞA İbrahim Halil,askin lutfu,SEVİMLİ Serdar Relation of multicenter automatic defibrillator implantation trial implantable cardioverter-defibrillator score with long-term cardiovascular events in patients with implantable cardioverter-defibrillator. (2019): 40 - 47. 10.14744/nci.2018.69335
MLA uslu Abdulkadir,Doğan Cem,duman hakan,TANBOĞA İbrahim Halil,askin lutfu,SEVİMLİ Serdar Relation of multicenter automatic defibrillator implantation trial implantable cardioverter-defibrillator score with long-term cardiovascular events in patients with implantable cardioverter-defibrillator. , 2019, ss.40 - 47. 10.14744/nci.2018.69335
AMA uslu A,Doğan C,duman h,TANBOĞA İ,askin l,SEVİMLİ S Relation of multicenter automatic defibrillator implantation trial implantable cardioverter-defibrillator score with long-term cardiovascular events in patients with implantable cardioverter-defibrillator. . 2019; 40 - 47. 10.14744/nci.2018.69335
Vancouver uslu A,Doğan C,duman h,TANBOĞA İ,askin l,SEVİMLİ S Relation of multicenter automatic defibrillator implantation trial implantable cardioverter-defibrillator score with long-term cardiovascular events in patients with implantable cardioverter-defibrillator. . 2019; 40 - 47. 10.14744/nci.2018.69335
IEEE uslu A,Doğan C,duman h,TANBOĞA İ,askin l,SEVİMLİ S "Relation of multicenter automatic defibrillator implantation trial implantable cardioverter-defibrillator score with long-term cardiovascular events in patients with implantable cardioverter-defibrillator." , ss.40 - 47, 2019. 10.14744/nci.2018.69335
ISNAD uslu, Abdulkadir vd. "Relation of multicenter automatic defibrillator implantation trial implantable cardioverter-defibrillator score with long-term cardiovascular events in patients with implantable cardioverter-defibrillator". (2019), 40-47. https://doi.org/10.14744/nci.2018.69335
APA uslu A, Doğan C, duman h, TANBOĞA İ, askin l, SEVİMLİ S (2019). Relation of multicenter automatic defibrillator implantation trial implantable cardioverter-defibrillator score with long-term cardiovascular events in patients with implantable cardioverter-defibrillator. İstanbul Kuzey Klinikleri, 6(1), 40 - 47. 10.14744/nci.2018.69335
Chicago uslu Abdulkadir,Doğan Cem,duman hakan,TANBOĞA İbrahim Halil,askin lutfu,SEVİMLİ Serdar Relation of multicenter automatic defibrillator implantation trial implantable cardioverter-defibrillator score with long-term cardiovascular events in patients with implantable cardioverter-defibrillator. İstanbul Kuzey Klinikleri 6, no.1 (2019): 40 - 47. 10.14744/nci.2018.69335
MLA uslu Abdulkadir,Doğan Cem,duman hakan,TANBOĞA İbrahim Halil,askin lutfu,SEVİMLİ Serdar Relation of multicenter automatic defibrillator implantation trial implantable cardioverter-defibrillator score with long-term cardiovascular events in patients with implantable cardioverter-defibrillator. İstanbul Kuzey Klinikleri, vol.6, no.1, 2019, ss.40 - 47. 10.14744/nci.2018.69335
AMA uslu A,Doğan C,duman h,TANBOĞA İ,askin l,SEVİMLİ S Relation of multicenter automatic defibrillator implantation trial implantable cardioverter-defibrillator score with long-term cardiovascular events in patients with implantable cardioverter-defibrillator. İstanbul Kuzey Klinikleri. 2019; 6(1): 40 - 47. 10.14744/nci.2018.69335
Vancouver uslu A,Doğan C,duman h,TANBOĞA İ,askin l,SEVİMLİ S Relation of multicenter automatic defibrillator implantation trial implantable cardioverter-defibrillator score with long-term cardiovascular events in patients with implantable cardioverter-defibrillator. İstanbul Kuzey Klinikleri. 2019; 6(1): 40 - 47. 10.14744/nci.2018.69335
IEEE uslu A,Doğan C,duman h,TANBOĞA İ,askin l,SEVİMLİ S "Relation of multicenter automatic defibrillator implantation trial implantable cardioverter-defibrillator score with long-term cardiovascular events in patients with implantable cardioverter-defibrillator." İstanbul Kuzey Klinikleri, 6, ss.40 - 47, 2019. 10.14744/nci.2018.69335
ISNAD uslu, Abdulkadir vd. "Relation of multicenter automatic defibrillator implantation trial implantable cardioverter-defibrillator score with long-term cardiovascular events in patients with implantable cardioverter-defibrillator". İstanbul Kuzey Klinikleri 6/1 (2019), 40-47. https://doi.org/10.14744/nci.2018.69335